These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8055241)

  • 21. Development of drugs for gastrointestinal motor disorders: translating science to clinical need.
    Sanger GJ; Alpers DH
    Neurogastroenterol Motil; 2008 Mar; 20(3):177-84. PubMed ID: 18257767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and treatment of enteric neuromuscular diseases.
    Camilleri M
    Clin Auton Res; 2003 Feb; 13(1):10-5. PubMed ID: 12664242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impacts and patterns of disturbed gastrointestinal function in critically ill patients.
    Ritz MA; Fraser R; Tam W; Dent J
    Am J Gastroenterol; 2000 Nov; 95(11):3044-52. PubMed ID: 11095317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrointestinal motility disorders.
    Abell TL; Werkman RF
    Am Fam Physician; 1996 Feb; 53(3):895-902. PubMed ID: 8594865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gastrointestinal motility in the elderly].
    Lux G; Bozkurt T; Orth KH
    Z Gerontol; 1992; 25(5):295-303. PubMed ID: 1441709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ion channels as targets for treatment of gastrointestinal motility disorders.
    Farrugia G
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():135. PubMed ID: 18924455
    [No Abstract]   [Full Text] [Related]  

  • 27. Intestinal and anorectal motility and functional disorders.
    Keller J; Layer P
    Best Pract Res Clin Gastroenterol; 2009; 23(3):407-23. PubMed ID: 19505668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders.
    Camilleri M; Bueno L; de Ponti F; Fioramonti J; Lydiard RB; Tack J
    Gastroenterology; 2006 Apr; 130(5):1421-34. PubMed ID: 16678556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thyroid-intestinal motility interactions summary].
    Pustorino S; Foti M; Calipari G; Pustorino E; Ferraro R; Guerrisi O; Germanotta G
    Minerva Gastroenterol Dietol; 2004 Dec; 50(4):305-15. PubMed ID: 15788986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small intestinal motor activity--its role in gut homeostasis and disease.
    Quigley EM
    Q J Med; 1987 Oct; 65(246):799-810. PubMed ID: 3329737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Equine gastrointestinal motility research: where we are and where we need to go.
    Hudson NP; Merritt AM
    Equine Vet J; 2008 Jun; 40(4):422-8. PubMed ID: 18487107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [On the possibility of using prokinetics in gastroenterology].
    Sheptulin AA; Vize-Khripunova MA
    Klin Med (Mosk); 2010; 88(5):19-22. PubMed ID: 21089451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastrointestinal motility in pregnancy.
    Everson GT
    Gastroenterol Clin North Am; 1992 Dec; 21(4):751-76. PubMed ID: 1478733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Access options for withdrawn motility-modifying agents.
    Jones MP
    Am J Gastroenterol; 2002 Sep; 97(9):2184-8. PubMed ID: 12358230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esophageal motility abnormalities in cirrhotic patients before and after endoscopic variceal treatment.
    Fass R; Landau O; Kovacs TO; Ippoliti AF
    Am J Gastroenterol; 1997 Jun; 92(6):941-6. PubMed ID: 9177506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neural control of the gastrointestinal tract: implications for Parkinson disease.
    Cersosimo MG; Benarroch EE
    Mov Disord; 2008 Jun; 23(8):1065-75. PubMed ID: 18442139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormones of the gut-brain axis as targets for the treatment of upper gastrointestinal disorders.
    Sanger GJ; Lee K
    Nat Rev Drug Discov; 2008 Mar; 7(3):241-54. PubMed ID: 18309313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tachykinin receptors as drug targets for motility disorders.
    Hoogerwerf WA; Sarna SK
    Dig Dis; 2006; 24(1-2):83-90. PubMed ID: 16699266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential of ghrelin as a therapeutic approach for gastrointestinal motility disorders.
    Peeters TL
    Curr Opin Pharmacol; 2006 Dec; 6(6):553-8. PubMed ID: 17011824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma).
    Sallam H; McNearney TA; Chen JD
    Aliment Pharmacol Ther; 2006 Mar; 23(6):691-712. PubMed ID: 16556171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.